Standard Contracts
ABBOTT LABORATORIES PERFORMANCE RESTRICTED STOCK UNIT AGREEMENTPerformance Restricted Stock Unit Agreement • February 19th, 2021 • Abbott Laboratories • Pharmaceutical preparations • Illinois
On «Grant_Date» (the “Grant Date”), Abbott Laboratories hereby grants to «First Name» «MI» «Last Name» (the “Employee”) a Performance Restricted Stock Unit Award (the “Award”) of «NoShares12345» restricted stock units (the “Units”).
ABBOTT LABORATORIES PERFORMANCE RESTRICTED STOCK AGREEMENTPerformance Restricted Stock Agreement • February 19th, 2021 • Abbott Laboratories • Pharmaceutical preparations • Illinois
On «Grant_Date» (the “Grant Date”), Abbott Laboratories hereby grants to «First Name» «MI» «Last Name» (the “Employee”) a Performance Restricted Stock Award (the “Award”) of « NoShares12345» Shares.
ABBOTT LABORATORIES PERFORMANCE RESTRICTED STOCK AGREEMENTPerformance Restricted Stock Agreement • February 19th, 2021 • Abbott Laboratories • Pharmaceutical preparations • Illinois
On «Grant_Date» (the “Grant Date”), Abbott Laboratories hereby grants to «First Name» «MI» «Last Name» (the “Employee”) a Performance Restricted Stock Award (the “Award”) of «NoShares12345» Shares.
U.S. $5,000,000,000 FIVE YEAR CREDIT AGREEMENT Dated as of November 12, 2020 among ABBOTT LABORATORIES, as Borrower, and VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and JPMORGAN CHASE BANK, N.A., as Administrative Agent, andCredit Agreement • February 19th, 2021 • Abbott Laboratories • Pharmaceutical preparations • New York
ABBOTT LABORATORIES, a corporation organized and existing under the Laws of the State of Illinois (the “Borrower”), the Lenders (as defined below) that are parties hereto, and JPMorgan Chase Bank, N.A. (“JPMorgan”), as administrative agent (together with any successor thereto appointed pursuant to Article VII, the “Administrative Agent”) for the Lenders, agree as follows:
Date] To: [Executive] Re: CIC Agreement Extension Change in Control Agreement • February 19th, 2021 • Abbott Laboratories • Pharmaceutical preparations
Abbott’s Board of Directors recently extended your Change in Control (CIC) agreement. Its term now continues through December 31, 2022. The CIC agreement provides you with financial, health and welfare benefits in the event of a Change in Control. No action is required on your part to continue participation in the CIC agreement.
TIME SHARING AGREEMENTTime Sharing Agreement • February 19th, 2021 • Abbott Laboratories • Pharmaceutical preparations • Illinois
WHEREAS, Company owns or rightfully possesses and operates the aircraft set forth in Exhibit A attached hereto (individually and collectively, as the context requires, the "Aircraft"); and
